baber/WOPTO huggingface dataset:
Patent AU-703810-B2 (AU)
Title: Environmental sealing
Inventor: WAMBEKE ALAIN
IPC: H02G9/06
Filed: 1995-02-24
Granted: 1999-04-01
Abstract: PCT No. PCT/GB95/00383 Sec. 371 Date Dec. 2, 1996 Sec. 102(e) Date Dec. 2, 1996 PCT Filed Feb. 24, 1995 PCT Pub. No. WO95/23448 PCT Pub. Date Aug. 31, 1995A device capable of co-operating with an outer pressure member to form a sealing block between two or more elongate substrates and a hollow housing within which the substrates extend, the device comprising i) an elongate support member and ii) two or more elongate flexible leaves each of which comprises a sealing material that (a) is not heat fusible, (b) is secured relative to the support member, and (c) extends laterally of the elongate support member, the device being positioned, in use, between the elongate substrates, so that a first of the flexible leaves extends at least part of the way around the periphery of a first of the elongate substrates, and a second of the flexible leaves extends at least part of the way around the periphery of a second of the elongate substrates, so that in co-operation with the action of the outer pressure member acting inwardly on the substrates and the device, and outwardly onto the housing, a sealing block is made between the elongate substrates and the housing.
Patent AU-765689-B2 (AU)
Title: A communication device
Inventor: MARQVARDSEN ION
IPC: H01Q5/10
Filed: 1999-12-20
Granted: 2003-09-25
Abstract: The invention relates to a communication device comprising a housing enclosing at least one loudspeaker and at least part of at least one antenna inside the housing. This at least one loudspeaker comprises an acoustic resonance chamber while said at least one antenna comprises at least one electromagnetic resonance chamber. The invention teaches that the acoustic resonance chamber can be located completely or partly within the electromagnetic resonance chamber.
Patent AU-617328-B2 (AU)
Title: A process for the preparation of bicyclic amino carboxylic acids, intermediates in this process, and their use
Inventor: URBACH HANSJORG
IPC: C07D209/52
Filed: 1988-07-01
Granted: 1991-11-28
Abstract: Compounds of the formula I 
<IMAGE>
 in which n is 1, 2 or 3, R denotes acyl and R<1> denotes alkyl, cycloalkyl, aralkyl or another carboxyl protecting group are prepared by free-radical cyclisation of compounds of the formula II 
<IMAGE>
 in which n, R and R<1> are as defined above and Hal denotes chlorine, bromine or iodine. Intermediates of this process and their use are also described.
Patent AU-728758-B2 (AU)
Title: Composition for the oxidation dyeing of keratinous fibres containing a laccase and dyeing method using this composition
Inventor: LANG GERARD
IPC: A61K8/99
Filed: 1999-01-12
Granted: 2001-01-18
Abstract: The invention relates to a ready-to-use mixture for tinting keratin fibres, especially human keratin fibres such as hair, comprising in a support material suitable for keratin materials: a) at least one laccase-type enzyme; at least one anionic surface-active agent selected from the group made up of the acylisethionates, acyltaurates, sulfosuccinates having a special structure, acylsarcosinates having a special structure, acyl glutamates, polyoxyalkylenated carboxylic acid ethers and their salts, fatty glucamide sulfates, alkyl galactoside uronates, anionic derivatives of alkyl polyglucoside, and mixtures thereof; and (c) at least one oxidation tint. The invention also relates to the hair tinting methods using the above mixture.
Patent AU-758029-B2 (AU)
Title: End member for a bone fusion implant
Inventor: MESSERLI DOMINIQUE D
IPC: A61F2/30
Filed: 2000-02-03
Granted: 2003-03-13
Abstract: An end member (10) for use with an implant for fusion of bones, particularly of vertebrae is disclosed. The end member (10) has a first portion (12), a second portion (14), and a shoulder (16) connecting the two portions (12; 14). The second portion (14) is sized to fit with the bone fusion implant in such a fashion that the shoulder rests on the edge of the implant. The top surface (18) of the first portion (12) has at least one channel (20) to receive a surgical instrument such as an inserter and/or distractor to facilitate implantation of the end member and bone fusion implant. The top surface (18) may also have teeth to provide initial mechanical stability between the bone and end plate and promote bone fusion.
Patent AU-600863-B2 (AU)
Title: Low stress flat end closure arrangement for thermoplastic coated paperboard carton
Inventor: LISIECKI ROBERT E
IPC: B65D5/06
Filed: 1988-10-24
Granted: 1990-08-23
Abstract: A flat end closure arrangement particularly for a paperboard carton which may include an aluminium foil barrier, wherein there are no overstressed folds and a minimum build-up of thicknesses, to minimise the tendency for fractures of the respective barriers to occur. Two oppositely disposed closure panels (12/20, 16) include provisions for the edge portion of their centre segments to overlap one another, while being covered by the remaining two oppositely disposed closure panels (14, 18). More specifically, the underlying closure panels each includes score lines which coverage toward the respective free edge of which panels, while one includes one horizontal score line (64) connecting two parallel vertical score lines (60, 62) which define the centre segment (16a') for folding back onto the closure panel (16a) beneath the centre segment (12a/20a)  of the other closure panel.
Patent AU-561701-B2 (AU)
Title: Substituted diazolylalkyl-carbinols
Inventor: ELBE HANS-LUDWIG
IPC: C07D/
Filed: 1984-02-27
Granted: 1987-05-14
Abstract: 1. Substituted di- or triazolylalkyl-carbinols of the general formula   see diagramm : EP0120276,P20,F1   in which A represents a nitrogen atom or the CH group ; B represents a nitrogen atom or the CH group ; X represents hydrogen and straight-chain or branched alkyl with 1 to 6 carbon atoms ; Y represents straight-chain or branched alkyl with 1 to 6 carbon atoms ; and, if X represents hydrogen, also straight-chain or branched alkenyl and alkinyl with in each case 3 to 6 carbon atoms and benzyl which is optionally mono- to trisubstituted in the phenyl part by identical or different substituents, substituents which may mentioned being : halogen, alkyl with 1 to 4 carbon atoms, alkoxy and alkylthio with in each case 1 to 4 carbon atoms, halogenoalkyl, halogenoalkoxy and halogenoalkylthio with in each case 1 to 2 carbon and 1 to 5 identical or different halogen atoms, such as preferably fluorine and chlorine atoms, nitro and cyano ; R represents phenyl which is optionally mono- to tri-substituted by identical or different substituents, preferred substituents which may be mentioned being : halogen, alkyl with 1 to 4 carbon atoms, alkoxy and alkylthio with in each case 1 to 4 carbon atoms, halogenoalkyl, halogenoalkoxy and halogenoalkylthio with in each case 1 to 2 carbon and 1 to 5 identical or different halogen atoms, such as preferably fluorine and chlorine atoms, nitro, cyano, hydroxyl, hydroxycarbonyl with 1 to 4 carbon atoms in the alkyl part, hydroximinoalkyl with 1 to 4 carbon atoms, alkoximinoalkyl with 1 to 4 carbon atoms in each alkyl part, and phenyl, phenoxy, benzyl and benzyloxy, each of which is optionally substituted by halogen and/or alkyl with 1 to 2 carbon atoms ; R furthermore preferably represents the grouping   see diagramm : EP0120276,P20,F2   wherein Alk**1 represents straight-chain or branched alkyl with 1 to 4 carbon atoms ; Alk**2 represents straight-chain or branched alkyl with 1 to 4 carbon atoms ; Alk**1 and Alk**2, together with the carbon atom to which they are bonded, represent a 3- to 7-centered cycloaliphatic ring ; and R**1 represents, straight-chain or branched alkyl with 1 to 6 carbon atoms, alkenyl with 2 to 4 carbon atoms and phenyl, phenylalkyl with 1 to 4 carbon atoms in the alkyl part, phenoxy, phenylthio, phenoxyalkyl with 1 to 4 carbon atoms in the alkyl part, phenylthioalkyl with 1 to 4 carbon atoms in the alkyl part, benzyloxy and benzylthio, each of which is optionally mono- to trisubstituted in the phenyl part by identical or different substituents, preferred possible substituents being the phenyl substituents alreadly mentioned for R.
Patent AU-567556-B2 (AU)
Title: Pyrimidine-thioalkyl-pyridine derivatives
Inventor: SCHICKANDER HELMUT
IPC: C07D401/12
Filed: 1984-04-19
Granted: 1987-11-26
Abstract: 1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Pyrimidine-thioalkylpyridine derivatives corresponding to the general formula  see diagramm : EP0124630,P12,F5  wherein R1 to R4 denote, independently of one another, hydrogen, C1 -C4 alkyl, halogen, amino or hydroxyl groups, R5 denotes a free electron pair or a C1 to C4 alkyl group, X denotes a halogen atom when R5 denotes a C1 -C4 alkyl group, m has the value 0 or 1, and the pyrimidine-thioalkyl group is attached in the 2-, 3- or 4-position of the pyridine ring, and their therapeutically acceptable acid addition salts. 1. Claims for the contracting state : AT Process for the preparation of pyrimidine- thioalkylpyridine derivatives corresponding to the general formula I  see diagramm : EP0124630,P13,F1  wherein R1 to R4 denote, independently of one another, hydrogen, C1 -C4 alkyl, halogen, amino or hydroxyl groups, R5 denotes a free electron pair or a C1 -C4 -alkyl group, X stands for a halogen atom when R5 stands for a C1 -C4 alkyl group, m has the value 0 or 1, and the pyrimidine-thioalkyl group is attached in the 2-, 3- or 4-position of the pyridine ring, and their therapeutically acceptable acid addition salts, characterised in that a) for the preparation of compounds corresponding to the general formula I in which m has the value 0, a compound corresponding to formula II  see diagramm : EP0124630,P13,F4 wherein R1 and R2 have the meaning indicated above and Me stands for an alkali metal atom is reacted with a picolyl chloride hydrohalide corresponding to the general formula III  see diagramm : EP0124630,P13,F6  wherein Hal denotes a halogen atom and in which the chloromethyl group is in the 2, -3- or 4-position of the pyridine group and R3 and R4 have the meaning indicated above, in the aqueous alcoholic alkali metal hydroxide solution, the alkali metal hydroxide being present in excess of the stoichiometric quantity, or in that b) for the preparation of compounds in which m has the value 1, a compound corresponding to the general formula IV  see diagramm : EP0124630,P13,F8  wherein R1 to R4 have the meanings indicated above, has added thereto an aquimolar proportion of an oxidising agent in an inert solvent and the resulting sulphinyl compound corresponding to the general formula V  see diagramm : EP0124630,P14,F2  is isolated, or c) for the preparation of compounds in which m has the value 0, a pyrimidine-thioalkylpyridine derivative corresponding to the general formula IV  see diagramm : EP0124630,P14,F3  wherein R1 to R4 have the meanings indicated above is reacted in a solvent with an equimolar quantity of an alkyl halide to form a compound corresponding to the general formula VI  see diagramm : EP0124630,P14,F4  and d) optionally the compound obtained in a) to c) is converted into a physiologically acceptable salt.
Patent AU-676805-B2 (AU)
Title: Method and apparatus for measuring piston position in a freepiston compressor
Inventor: REDLICH ROBERT W
IPC: F04B49/00
Filed: 1995-07-26
Granted: 1997-03-20
Abstract: A method of measuring the distance at closest approach between the piston of a free piston compressor and the cylinder head. The method derives measurements of both the alternating and average components of piston position from direct measurements of the voltage and current applied to the linear permanent magnet motor that drives the piston, and thus eliminates any requirement for an additional position sensor located within the compressor.
Patent AU-696669-B2 (AU)
Title: Gel formulation
Inventor: TADROS THARWAT FOUAD
IPC: A01N43/90
Filed: 1995-07-06
Granted: 1998-09-17
Abstract: A water dispersible gel comprising:(a) an effective amount of an ionic, water soluble agrochemical;(b) an effective amount of a cross-linked polyacrylic acid;(c) water; and,(d) an amount of a base sufficient to cause a mixture of (a), (b) and (c) to gel.
Patent AU-653074-B2 (AU)
Title: Anode for a direct-current electric arc furnace
Inventor: MEREDITH DANE
IPC: H05B7/12
Filed: 1992-11-02
Granted: 1994-09-15
Abstract: The invention relates to an anode which has a wear behaviour which is approximately uniform locally and can be matched in simple form to various embodiments of DC arc furnaces. In this case, a plurality of contact plates are arranged symmetrically on an electrically conductive baseplate. The electrical current flow right into the melt bath is secured via rails which are located on the outside of the furnace, a copper ring which is surrounded by an electrically non-conductive ramming mass in the interior of the furnace jacket, the baseplate, the foot plates of the individual contact segments and sheet-metal plates which are located thereon. The sheet-metal plates are in this case likewise surrounded by an electrically non-conductive ramming mass and only their surface end area projects into the melt bath.
Patent AU-563923-B2 (AU)
Title: Tetrahydro-beta-carboline derivatives
Inventor: IIJIMA IKUO
IPC: C07D471/02
Filed: 1984-05-31
Granted: 1987-07-30
Abstract: Tetrahydro- beta -carboline derivatives of the formula:   <IMAGE> (I) wherein R1 is hydrogen atom, a lower alkyl group, a cycloalkyl group, phenyl group or a hydroxy-substituted lower alkyl group, R2 is hydrogen atom, an alkyl group, or a group of the formula: -(CH2)mY, Y is thienyl or a substituted or unsubstituted phenyl group, and m and n are an integer of 1 or 2, which have excellent alleviating, curing and preventing hepatic damages and are useful as a therapeutic or prophylactic agent for hepatic diseases, and a process for the preparation of said compounds.
Patent AU-779238-B2 (AU)
Title: Use of pyridoxine compounds for treatment of carsiovascular and related pathologies
Inventor: DHALLA NARANJAN S
IPC: A61K31/4418
Filed: 2000-03-22
Granted: 2005-01-13
Abstract: Compositions and methods for treatment and prevention of hypertrophy, hypertension, congestive heart failure, ischemic heart disease, ischemia-related conditions, such as ischemia reperfusion injury and cellular dysfunction, are described. The methods are directed to administering pharmaceutical compositions containing at least one compound selected from pyridoxal-5'-phosphate, pyridoxine, pyridoxal, and pyridoxamine.
Patent AU-575588-B2 (AU)
Title: Extraction of human-y interferon of 18 kdalton using the protease inhibitor guanidine-hcp
Inventor: KUNG HSIANG-FU
IPC: C12P21/02
Filed: 1984-09-19
Granted: 1988-08-04
Abstract: A method for the extraction of intact recombinant human immune interferon with guanidine-HCl is disclosed. This method permits the purification to homogenity of intact recombinant human immune interferon.
Patent AU-2001233945-B2 (AU)
Title: Motor control for two motors
Inventor: RAIMONDI GIOVANNI MARIO
IPC: D06F37/30
Filed: 2001-02-23
Granted: 2003-11-06
Abstract: A load in an electrical apparatus is driven by two motors M1, M2. Switching means (R1, R2) switches the motors M1, M2 between: a series configuration, in which the motors M1, M2 are connected in series across a power supply and driven with a dc supply; and a parallel configuration in which the motors M1, M2 are connected in parallel across the power supply and driven with an ac supply. In the series configuration, a bridge rectifier BR is switched across the ac supply to provide the dc supply for the motors M1, M2 and in the parallel configuration, the rectifier BR is removed from the circuit. The arrangement can be used to drive a drum of a washing machine or a load in some other kind of appliance.
Patent AU-555523-B2 (AU)
Title: A process for preparing advanced epoxy resins containing triazine or both triazine and oxazoline groups
Inventor: HEFNER ROBERT E JR
IPC: C08G59/14
Filed: 1984-10-25
Granted: 1986-09-25
Abstract: This invention pertains to a process for preparing advanced epoxy resins which contain triazine groups or both triazine and oxazoline groups. When cured, these resins have higher heat distortion temperatures and'or higher elongation values than advanced epoxy resins which do not contain triazine groups or triazine and oxazoline groups.
Patent AU-2002235744-B2 (AU)
Title: RNA interference mediating small RNA molecules
Inventor: TUSCHL THOMAS
IPC: C12N15/113
Filed: 2001-11-29
Granted: 2007-04-19
Abstract: Double-stranded RNA (dsRNA) induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). Using a Drosophila in vitro system, we demonstrate that 19-23 nt short RNA fragments are the sequence-specific mediators of RNAi. The short interfering RNAs (siRNAs) are generated by an RNase III-like processing reaction from long dsRNA. Chemically synthesized siRNA duplexes with overhanging 3' ends mediate efficient target RNA cleavage in the lysate, and the cleavage site is located near the center of the region spanned by the guiding siRNA. Furthermore, we provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the produced siRNP complex.
Patent AU-612489-B2 (AU)
Title: Flexible housing
Inventor: MARTIN JAMES DUNCAN SHAW
IPC: H02G3/04
Filed: 1989-05-30
Granted: 1991-07-11
Abstract: A flexible housing, for use in protecting one or more microwave transmission lines in a pressurised environment comprises a conduit (10) contained within encasing means (12). The conduit is constructed of a plurality of conduit segments (18,118), each segment having an opening (28) therethrough defining a through axis (36), the segments (18,118) being arranged in series and caused to abut adjacent segments in such a way that the opening through each segment is in communication with the openings through each of the adjacent segments so as to provide a passage to contain a microwave transmission line. Each segment (18,118) is flexibly linked to its adjacent segments by coupling means (34).
Patent AU-758715-B2 (AU)
Title: Method and preparation for the photochromic marking and/or for securing the authenticity of objects
Inventor: HAMPP NORBERT
IPC: C09K11/06
Filed: 2000-03-31
Granted: 2003-03-27
Abstract: Method and preparation for the photochromic labeling and/or for protecting the authenticity of objects, in which bacteriorhodopsin materials and preparations therefrom are used for application to the objects; preference is given to using a combination of low-level and high-level security features in said bacteriorhodopsin materials and preparations therefrom.
Patent AU-780227-B2 (AU)
Title: Method and apparatus for power control of multiple channels in a wireless communication system
Inventor: CHEN TAO
IPC: H04J3/00
Filed: 2001-02-13
Granted: 2005-03-10
Abstract: Techniques to control the transmit power of multiple transmissions in wireless communication system. A transmitting source (e.g., a base station) receives from a receiving device (e.g., a remote terminal) a first and a second transmission. The transmitting source derives an initial transmit power level for the second transmission, elects a power control mode based on the operating conditions of the first and the second transmission, and signals the selected power control mode to a remote terminal.
Patent AU-576840-B2 (AU)
Title: 1,2,4-thiadiazines
Inventor: JONES STUART DONALD
IPC: C07D285/18
Filed: 1985-04-02
Granted: 1988-09-08
Abstract: Novel 1,2,4-thiadiazines of the formula    <IMAGE>  I  wherein R3 is selected from the group consisting of hydrogen, -OH, -CF3, alkyl, alkoxy and alkylthio of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms optionally substituted with alkyl of 1 to 6 carbon atoms and   <IMAGE>  R1 and R2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 3 carbon atoms or taken together with the nitrogen to which they are attached form a saturated heterocycle of 4 to 8 carbon atoms optionally containing a heteroatom of the group consisting of -O-, -S- and   <IMAGE>  and R' is hydrogen or alkyl of 1 to 3 carbon atoms, R5 is   <IMAGE>  R4 is selected from the group consisting of hydrogen, halogen and alkyl and alkoxy of 1 to 3 carbon atoms, R6 is selected from the group consisting of hydrogen, halogen and alkyl of 1 to 3 carbon atoms with the proviso that R6 may represent halogen only when R3 is hydrogen, -OH, alkyl and alkoxy of 1 to 6 carbon atoms or cycloalkyl of 3 to 6 carbon atoms optionally substituted with alkyl of 1 to 6 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having a remarkable anxiolytic activity and novel intermediates.
Patent AU-616554-B2 (AU)
Title: Load sharing femoral hip implant
Inventor: SMITH TODD
IPC: A61F2/36
Filed: 1989-08-30
Granted: 1991-10-31
Abstract: A controlled stiffness elongated implant for use in the hip or other appropriate body joint. In the instance of the hip, a ball member fixed to the femur is rotatably engaged with a cup-shaped socket member fixed to the acetabulum of the pelvic bone. The ball member is mounted on one end of a femoral component which has an elongated stem receivable in the intramedullary canal of the femur. The stem has a generally longitudinally directed reduced mid-stem section. The dimension of the reduced mid-stem section is uniform or variable between the proximal and distal ends so as to affect the mass moment of inertia at any given location along the length of said stem to thereby achieve an optimal stem flexibility.
Patent AU-681590-B2 (AU)
Title: Passivated and stabilized porous supports and methods for the preparation and use of same
Inventor: GIROT PIERRE
IPC: B01J39/16
Filed: 1993-06-18
Granted: 1997-09-04
Abstract: This invention relates generally to modified porous solid supports and processes for the preparation and use of same. In particular, passivated porous mineral oxide, polymeric, or polymer-coated mineral oxide supports are disclosed which are characterized by a reversible high sorptive capacity substantially unaccompanied by non-specific adsorption of or interaction with biomolecules. Passivation is achieved by use of a passivation mixture comprising a main monomer, a passivating monomer and a crosslinking agent, which mixture upon polymerization results in the substantial elimination of the undesirable non-specific interaction with biomolecules.
Patent AU-765893-B2 (AU)
Title: Method of inactivating viruses
Inventor: DUBBELMAN THOMAS MARINUS ALBER
IPC: A61L2/08
Filed: 1999-06-23
Granted: 2003-10-02
Abstract: The invention relates to a method of inactivating viruses in an erythrocytes-containing liquid with the use of light, wherein a sensitizer is added to the liquid. Further, an erythrocyte-binding agent is added to the liquid, which protects against the influence of singlet oxygen and/or radicals.
Patent AU-674533-B2 (AU)
Title: Novel concentrated aqueous emulsions of neophanes and azaneophanes
Inventor: ROECHLING HANS
IPC: C09K23/42
Filed: 1993-09-23
Granted: 1997-01-02
Abstract: Concentrated aqueous emulsions of compounds of the general formula I   <IMAGE>  in which     A and B independently of one another represent CH, CR4 or N,   X represents CH2, O or S,   Y represents CH or N,   Z represents H or F, R1 and R4 independently of one another represent H, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, (C1-C3 )-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-haloalkylthio or R1 and R4 together represent -CH2-O-CH2-;   R2 represents H, (C1-C3)-alkyl, ethynyl, vinyl, halogen or cyano,   R3 represents H, halogen, (C1-C4)-alkyl, (C1-C3)-alkoxy and   M represents C or Si, characterised in that they contain (C12-C14)-fatty alcohols with a low degree of ethoxylation and a narrow range of homologs in combination with an anionic emulsifier and a non-ionic propylene oxide/ethylene oxide block oxyalkylate, have a good shelf life, good pourability and environmentally friendly and user-friendly properties.